info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Healthcare » Artificial Cornea and Corneal Implant Market Report, 2030

Artificial Cornea and Corneal Implant Market By Type (Artificial Cornea, Human Cornea), Implantation Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Others), Disease manifestation (Keratoconus, Fungal Keratitis, Fuchs’ Dystrophy, Others), By Geography, Segment revenue Estimation, Forecast: 2021-2030

Published On: Dec-2021   |   Base Year: 2021   |   No Of Pages: 140   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 86712132

Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Type & Diseases

The global artificial cornea and corneal implant market will witness a robust CAGR of 6.9%, valued at $ 421 million in 2021, expected to appreciate and reach $ 767.50 million by 2030, confirms Strategic Market Research. The artificial cornea transplantation method involves suturing natural cornea tissue from a donor’s eye to replace a specific layer of the cornea. However, there is a global shortage of cornea donors and eye and tissue banking since these are not prevalent in various countries. Meanwhile, there is always a risk that the human eye will reject the transplantation process, resulting in infection or visual loss. Cornea implants treat keratoconus, degenerative conditions, and many more. Keratoconus is a condition of the eye cornea’s structure, causing vision loss and affects about one in every 2,000 people, usually starting in puberty and progressing into the mid-30s. In addition, an artificial cornea may be supplied to individuals with repeated corneal graft failure. A keratoprosthesis (KPro) is an artificial cornea material implant made of synthetic or prosthetic material. The Boston keratoprosthesis (Boston KPro) is the most prevalent one. In other terms, it is a surgical process involving replacing a defective cornea with an artificial cornea. Usually, keratoprosthesis is indicated after one or more donor corneal transplants have failed. Polymers like silica are used to create artificial cornea tissue. Artificial cornea implants are of two types, i.e., Synthetic cornea implants and biosynthetic cornea implants.

Artificial Cornea and Corneal Implant Market Infographics

The Effects of Covid-19 on Artificial Corneas and Corneal Implant Market

Due to lockdowns and limits enacted to prevent the spread of the COVID-19 epidemic, the number of patient visits to clinics decreased significantly in the first and second quarters of 2020. As a result, Hospitals and clinics perform fewer elective eye procedures each week than they did in the past. According to an article in Ophthalmology Times, elective procedures have decreased from 200 to only ten each week. In addition, in countries such as the United States, patient visits to examination facilities have been reduced by 15%. According to the same article, it was reported that ophthalmology suffered a considerable loss of patient volume during the coronavirus disease (COVID-19) pandemic.

During the starting phases of the COVID-19 outbreak, the worldwide government-imposed restrictions and prohibitions on medical operations and elective surgeries to restrict the virus’s contamination. Due to these restrictions, artificial cornea makers struggled to give in-person product presentations, operate at total capacity, and attend or organize conferences. Furthermore, due to lockdown in APAC nations such as China and India, the shipment & production of ophthalmics were delayed; these restrictions hindered the demand for ophthalmic surgeries.

 

Artificial Cornea and Corneal Implant Market By Endothelial Keratoplasty Penetrating Keratoplasty and Others

Market Drivers: Increasing Incidences of Corneal Blindness, Eye Injury, and  Scare Number of Cornea Donors Driving the Growth of the Market

Corneal blindness affects around 10 million individuals on a worldwide basis. As a result, the critical factor driving the expansion of artificial cornea implants is the increased incidence of corneal blindness. Furthermore, the scarcity of human cornea donors has contributed to the market’s rapid development. Moreover, when the number of trauma cases rises, there is a greater risk of eye injury, which will drive the market forward. The chance of nerve regeneration following a human donor cornea transplant is low, whereas a biosynthetic cornea implant has a high probability of nerve regeneration after implantation. In heavily populated regions like India, donors for corneas are scarce, and patients with corneal blindness must wait for a long time for corneal transplants. Around 6.8 million people in the country have poor vision in one eye due to corneal abnormalities, while approximately one million people have poor vision in both eyes.

 

Restraint: Regulatory diificulties, high cost, technological complexity, andSurgical proficiency are Set to Limit the Market Growth

 

  • Regulatory Difficulties: Creating and obtaining regulatory approval for novel medical equipment, like prosthetic corneas, can be an expensive and time-consuming procedure. Strict legal regulations might make it more difficult for firms to enter a market and raise their expenses.

 

  • Cost: The production and acquisition of artificial corneas and corneal implants can be costly. Cost-effectiveness in relation to alternative therapies or orthodox treatments could be a barrier, particularly in areas with tight healthcare budgets or problems with reimbursement.

 

  • Technological Complexity: It is difficult to create cutting-edge materials and technologies that replicate the natural functioning of the cornea. Larger R&D expenditures are necessary for innovations, which may discourage smaller businesses from joining the market.

 

  • Surgical Proficiency: The implantation of prosthetic corneas necessitates specific surgical abilities and facilities. Widespread surgery may be hampered by the lack of qualified surgeons or adequate surgical facilities.

 

Artificial Cornea and Corneal Implant By Market Share

Opportunity: The Increasing Demand for Artificial Cornea and Its Implant and Technological Enhancement in The Same Set Provide Various Opportunities in The Market

The high prevalence of corneal blindness, along with a scarcity of corneal donors, is predicted to provide high-growth possibilities for corneal implant producers. Furthermore, because of the rising frequency of corneal infection, the artificial cornea implant market is expected to rise exponentially throughout the forecast period. In addition, the demand for these cornea implants has grown in the global market due to increased visual handicaps among working people due to clouded corneas.

 

Market Analysis Of Different Segments Covered in the Report

By Implantation Type

  • Endothelial Keratoplasty

  • Penetrating Keratoplasty

  • Others

Type Segment contains Human Cornea and Artificial Cornea

By Disease Manifestation

  • Keratoconus

  • Fungal Keratitis

  • Fuchs’ Dystrophy

  • Others

 

By Type

  • Artificial Cornea

  • Human Cornea

 

By End-User

  • Specialty Clinics & ASCs

  • Hospitals

End-User Dominated by Specialty Clinics & ASCs and Hospitals

Regional Coverage Analysis

North America

  • United States

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • Italy

  • Switzerland

  • United Kingdom

  • Rest of Europe

 

Asia-Pacific

  • Japan

  • China

  • India

  • Rest of Asia-Pacific

 

LAMEA

  • Brazil

  • Israel

  • South Africa

  • Saudi Arabia

  • Rest of LAMEA

Artificial Cornea And Corneal Implant Dominating All Region

Type Analysis & Insights

On the basis of type, the ‘human cornea’ sector accounts for the largest Artificial Cornea and Corneal Implant market share due to its long-standing success and reliability. Annually, around 185,000 corneal transplants are performed globally, highlighting its widespread acceptance and adoption among surgeons and patients. The widespread availability of donor corneas and the familiarity of surgeons with transplantation techniques contribute to its preference over synthetic alternatives. Additionally, the lower risk of complications such as rejection and the ability to address a wide range of corneal conditions make human corneas the leading choice in this market.

 

Disease Manifestation Analysis & Insights

On the basis of disease manifestation, the Fuchs’ dystrophy segment led the market with 52% of the market share. The 'Fuchs' dystrophy' segment holds the largest market share in the artificial cornea and corneal implant market due to the high prevalence and progressive nature of this disease. As the leading cause of corneal transplants in many regions, the demand for effective treatment options, including artificial corneas and corneal implants, is substantial.

 

End-User Analysis & Insights

The market is dominated by the ‘specialty clinics’ category based on the End-User. The decline in inpatient surgeries and the increasing preference for more minor invasive procedures contribute to this segment’s development. Patient preferences fuel the segment’s rise for effective treatment and worries about hospital-acquired illnesses. Most ambulatory surgical institutions prefer biosynthetic cornea implants rather than synthetic cornea implants. As a result, the worldwide artificial corneal implant market is likely to dominate biosynthetic corneal implants.

 

Regional Analysis & Insights

North America was the largest regional market with 48.31% of revenue share. The need for corneal implants is fueled by the high frequency of corneal disorders and the aging population. A consistent supply of donor corneas is also guaranteed by the government's and nonprofits' strong support of eye donation and transplant programs. In 2020, the U.S. recorded around 85,441 corneal transplants, underscoring the effectiveness of its eye donation programs. The Eye Bank Association of America (EBAA) facilitates these programs, contributing to a reliable supply of donor corneas. North America also has a high concentration of skilled ophthalmic surgeons and specialized eye care centers, facilitating the widespread adoption of advanced corneal implant procedures.

 

Artificial Cornea and Corneal Implant Market Report Coverage

Report Attribute

Details         

Forecast Period

2021 - 2030

The market size value in 2021

USD  421 Million

The revenue forecast in 2030

USD  767.50 Million

Growth rate

CAGR of approximately 6.9%

The base year for estimation

2021

Historical data

2017 – 2021

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Implantation Type, By Disease manifestation, By Type, By Application, By Region.

By Implantation Type

Endothelial Keratoplasty, Penetrating Keratoplasty, Others.

By Disease Manifestation

Keratoconus, Fungal Keratitis, Fuchs’ Dystrophy, Others.

By Type

Artificial Cornea, Human Cornea.

By End-User

Specialty Clinics & ASCs, Hospitals.

By Region

North America, Europe, Asia-Pacific, LAMEA.

Country Scope

U.S., Canada, France, Germany, U.K., China, Japan, India,  South Korea,  Mexico, Brazil, U.A.E., etc.

Company Usability Profiles

CorneaGen, AJL Ophthalmic, LinkoCare Life Sciences AB, Addition Technology, Mediphacos, Florida Lions Eye Bank, Presbia plc, Aurolab, EyeYon Medical, Advancing Sight Network, Massachusetts Eye and Ear, DIOPTEX GmbH, San Diego Eye Bank, SightLife, Cornea Biosciences.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs.

 

 

 

Global Artificial Cornea and Corneal Implant Market Competitive Landscape Analysis

Key market players operating in the market include 

  • CorneaGen, 

  • AJL Ophthalmic, 

  • LinkoCare Life Sciences AB, 

  • Addition Technology, 

  • Mediphacos, 

  • Florida Lions Eye Bank, 

  • Presbia plc, 

  • Aurolab, 

  • EyeYon Medical, 

  • Advancing Sight Network, 

  • Massachusetts Eye and Ear

  • DIOPTEX GmbH, 

  • San Diego Eye Bank, 

  • SightLife, 

  • Cornea Biosciences, 

 

Recent Development

 

  • In February 2024, Researchers at the University of Melbourne received a $35 million grant from the Australian Government Medical Research Future Fund (MRFF) to support the development of a world-first tissue-engineered cornea. Corneal blindness is a global challenge caused by disorders that damage and scar the transparent layer of our eyes. BIENCO has been granted funds to develop superior, specifically designed, and reasonably priced corneas in an effort to treat one of the most prevalent causes of blindness worldwide. Just one in seventy people worldwide have access to donor corneas at this time.

 

  • In November 2023, Pantheon Vision has begun developing bioengineered corneal implants to treat corneal blindness with $2.5 million in seed investment. KeraLink International, a nonprofit organization, founded the US-based ophthalmic equipment company. Pantheon seeks to end corneal blindness in developed and low- and middle-income countries (LMICs) by treating corneal implants with bioengineered implants. It is anticipated that the implants will serve as a good stand-in for the corneal tissue provided, therefore minimizing the need for donors. 3D-printed artificial corneas are one method of creating corneal implants.

Frequently Asked Question About This Report

By type Penetrating Keratoplasty and Endothelial Keratoplasty have been included in this report.

North America is dominating in the market.

Penetrating Keratoplasty is the leading transplant type in the market.

Fuchs Dystrophy is the leading disease indication segment of the market.

Specialty clinics are the leading end-user segment of the market.

It is predicted to reach USD 767.50 Million by 2030.

The global artificial cornea and corneal implant market size was $421 million in 2021. It is estimated to reach $767.50 million by 2030, representing a CAGR of 6.9% throughout the forecasted period of 2021-2030.


Sources

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438571/


 

Chapter 1. Introduction
     1.1 Study Objectives
     1.2 Market Definition
            Table 1 Inclusions and Exclusions
     1.3 Study Scope
            1.3.1 Markets Covered
                      Figure 01: Market Segmentation
            1.3.2 Geographic Scope

                      Figure 02: Market Geography covered
            1.3.3 Years Considered
     1.4 Stakeholders

Chapter 2. Research Methodology

      2.1 Data Procurement

      2.2 Paid Database

             2.2.1 Secondary Data

                       2.1.2.1 Key Secondary sources

             2.2.2 Primary Data

                      2.2.2.1 Primary sources

                      2.2.2.2 Key industry insights

                      2.2.2.3 Primary interviews with experts

                      2.2.2.4 Key primary respondent list

      2.3 Market Size Estimation

      2.4 Bottom-Up and Top-Down Approaches

             2.4.1 Bottom-Up Approach

                       2.4.1.1 Approach for arriving at market size by bottom-up analysis

                                    Figure 03: Market: Bottom-Up Approach

             2.4.2 Top-Down Approach

                       2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis

                                    Figure 04: Market: Top-Down Approach

        2.5 Market Breakdown and Data Triangulation

               Figure 05: Data Triangulation

         2.6 Research Methodology

         2.7 Risk Assessment

               Table 2: Risk Assessment

Chapter 3. Executive Summary

          3.1 Market: Post-Covid-19

                Figure 06: Impact of Covid-19 on Market

                          3.1.1 Actual Scenario

                                    Figure 07: Realistic Scenario: Market, 2021–2030 (USD Million)

                          3.1.2 Pessimistic Scenario

                                    Figure 08: Pessimistic Scenario: Market, 2021–2030 (USD Million)

                          3.1.3 Optimistic Scenario

                                    Figure 09: Optimistic Scenario: Market, 2021–2030(USD Million)

                          3.1.4 Market Summary

                                    Figure 10: Human Cornea to Witness Highest CAGR in Market, By Type, During Forecast Period

                                  Figure 11: Specialty clinics to Witness Higher CAGR in Market for End-User Segment during Forecast Period

                                  Figure 12: Fuchs’ dystrophy for Disease manifestation to Register Highest CAGR in Market during Forecast Period

                                  Figure 13: Penetrating Keratoplasty for Implantation Type to Register Highest CAGR in Market during Forecast Period

                                  Figure 14: North America to Account for Largest Share of Global Market In 2021

Chapter 4. Market Definitions

      4.1 Market Segmentation

             Figure 15: Market Segmentation

Chapter 5. Industry Outlook
      5.1 Artificial Cornea and Corneal Implant Market Snapshot

      5.2 Global Market
              5.2.1 Global Market, 2021 – 2030 (USD Million)
      5.3 Regional Segment Analysis
             5.3.1 Global Market, by region, 2021 - 2030 (USD Million)
      5.4 Type Segment Analysis
             5.4.1 Global Market, by Type, 2021 - 2030 (USD Million)
      5.5 End-User Analysis
             5.5.1 Global Market, By End-User, 2021 - 2030 (USD Million)
      5.6 Disease manifestation Segment Analysis
             5.6.1 Global Market, by Disease manifestation, 2021 - 2030 (USD Million)
      5.7 By Disease manifestation Business Analysis
      5.8 Value Chain Analysis
      5.9 Market Variable Analysis
             5.9.1 Market Drivers Analysis
             5.9.2 Market Restraints Analysis

      5.10 Business Environment Analysis Tool
               5.10.1 Market PEST analysis
               5.10.2 Market Porter’s analysis
      5.11 Penetration & Growth Prospect Mapping
Chapter 6. Market Overview

     6.1 Introduction

     6.2 Market Dynamics

            Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges

                 6.2.1 Drivers

            Figure 17 Market Drivers and Their Impact

                 6.2.2 Restraints

            Figure 18 Market Restraints and Their Impact

                 6.2.3 Opportunities

            Figure 19 Market Opportunities and Their Impact

                 6.2.4 Challenges

            Figure 20 Market Challenges and Their Impact

     6.3 Impact of Covid-19 on Market

     6.4 Value Chain Analysis

            Figure 21 Value Chain Analysis: Market

     6.5 Ecosystem

               Figure 22 Market: Ecosystem

Table 3 Market: Ecosystem

               Figure 23 Revenue Shift in Market

     6.6 Patent Analysis

Table 4 Number of Patents Registered in Market in USA in Last 9 Years

                Figure 24 Top 15 Companies with Highest No. of Patents in Last 9 Years

                Figure 25 No of Patents Granted Per Year, 2019–2021

Table 5 List of Global Patents in Market

     6.7 Trade Analysis

                Figure 26 Import Data for Artificial Cornea, By Country, 2016–2021 (USD Thousand)

Table 6 Import Data for Human Cornea, By Country, 2016–2021 (USD Thousand)

                Figure 27 Export Data for Artificial Cornea, By Country, 2016–2021 (USD Thousand)

Table 7 Export Data for Human Cornea, By Country, 2016–2021 (USD Thousand)

     6.8 Tariff Analysis

     6.9 Case Study Analysis

     6.10 Porter’s Five Forces Analysis

Table 8 Market: Porter’s Five Forces Analysis, 2021

             6.10.1 Threat of New Entrants

             6.10.2 Threat of Substitutes

             6.10.3 Bargaining Power of Buyers

             6.10.4 Bargaining Power of Suppliers

             6.10.5 Degree of Competition

     6.11 Technology Analysis

             6.11.1 Trends in Technology (2014-2021)

             6.11.2 Trends in Technology (2021-2030)

                    Table 9 Key Regulations: Market

     6.12 Pricing Analysis

              6.12.1 Average Price Trend Analysis (By region, By Countries)

Chapter 7. Competitive & Vendor Landscape

     7.1 Company Market Share Analysis

                   Table 10: Key Players market share

             Figure 28: Key players market share of companies

     7.2 Manufacturers Artificial Cornea and Corneal Implant Manufacturing Sites, Area Served, Product Type

     7.3 Market Competitive Situation and Trends

     7.4 Manufacturers Mergers & Acquisitions, Expansion Plans

Chapter 8. Global Market: Type Segment Analysis

     8.1 Introduction

     8.2 Sales Volume & Revenue Analysis (2021-2030)

                    Table 11 Market, By Type, 2021–2030 (USD Million)

            Figure 29 Market, By Type

            Figure 30 Human Cornea Segment to Register Highest CAGR in Market During Forecast Period

     8.3 Human Cornea

            8.3.1 Human Cornea market, 2021 - 2030 (USD Million)

            Figure 31: Human Cornea market, 2021 - 2030 (USD Million)

     8.4 Artificial Cornea

            8.4.1 Artificial Cornea market, 2021 - 2030 (USD Million)

            Figure 32: Artificial Cornea market, 2021 - 2030 (USD Million)

Chapter 9. Global Market: End-User Segment Analysis

     9.1 Introduction

     9.2 Sales Volume & Revenue Analysis (2021-2030)

                   Table 12: Market, By End-User, 2021–2030 (USD Million)

           Figure 33: Market, By End-User, 2021–2030 (USD Million)

           Figure 34: Specialty Clinics Segment to Register Highest CAGR in Market during Forecast Period

     9.3 Specialty Clinics & ASCs

            9.3.1 Specialty Clinics & ASCs market, 2021 - 2030 (USD Million)

            Figure 35: Specialty Clinics & ASCs market, 2021 - 2030 (USD Million)

     9.4 Hospitals

           9.4.1 Hospitals market, 2021 - 2030 (USD Million)

           Figure 36: Hospitals market, 2021 - 2030 (USD Million)

Chapter 10. Global Market: Disease manifestation Segment Analysis

     10.1 Introduction

     10.2 Sales Volume & Revenue Analysis (2021-2030)

                     Table 13: Market, By Disease manifestation, 2021–2030 (USD Million)

              Figure 37: Market, By Disease manifestation, 2021–2030 (USD Million)

              Figure 38: Fuchs’ dystrophy Segment to Register Highest CAGR in Market during Forecast Period

     10.3 Keratoconus

              10.3.1 Keratoconus market, 2021 - 2030 (USD Million)

              Figure 39: Keratoconus market, 2021 - 2030 (USD Million)

     10.4 Fungal Keratitis

             10.4.1 Fungal Keratitis market, 2021 - 2030 (USD Million)

              Figure 40: Fungal Keratitis market, 2021 - 2030 (USD Million)

10.5 Fuchs’ Dystrophy

             10.5.1 Fuchs’ Dystrophy market, 2021 - 2030 (USD Million)

              Figure 41: Fuchs’ Dystrophy market, 2021 - 2030 (USD Million)

 10.6 Others

              10.6.1 Other Disease manifestation market, 2021 - 2030 (USD Million)

              Figure 42: Other Disease manifestation market, 2021 - 2030 (USD Million)

Chapter 11. Global Market: Implantation Type Segment Analysis

     11.1 Introduction

     11.2 Sales Volume & Revenue Analysis (2021-2030)

                     Table 14: Market, By Implantation Type, 2021–2030 (USD Million)

              Figure 43: Market, By Implantation Type, 2021–2030 (USD Million)

              Figure 44: Penetrating Keratoplasty Segment to Register Highest CAGR in Market during Forecast Period

     11.3 Endothelial Keratoplasty

              11.3.1 Endothelial Keratoplasty market, 2021 - 2030 (USD Million)

              Figure 45: Endothelial Keratoplasty market, 2021 - 2030 (USD Million)

     11.4 Penetrating Keratoplasty

             11.4.1 Penetrating Keratoplasty market, 2021 - 2030 (USD Million)

              Figure 46: Penetrating Keratoplasty market, 2021 - 2030 (USD Million)

11.5 Others

              11.5.1 Other Implantation Type market, 2021 - 2030 (USD Million)

              Figure 47: Other Implantation Type market, 2021 - 2030 (USD Million)

Chapter 12. Global Market: Regional Outlook

     12.1 North America

              Figure 48: North America Market, By Revenue Forecast (2021-2030)

              12.1.1 North America Market, by country, 2021 - 2030 (USD Million)

                      Table 15: North America Market, by Country, 2021-2030

              Figure 49: North America Market

              12.1.2 North America Market, by Type, 2021 - 2030 (USD Million)

                       Table16: North America Market, by Type, 2021 - 2030 (USD Million)

               Figure 50: North America Market, by Type, 2021 - 2030 (USD Million)

               12.1.3 North America Market, by End-User, 2021 - 2030 (USD Million)

                     Table 17: North America Market, by End-User, 2021 - 2030 (USD Million)

              Figure 51: North America Market, by End-User, 2021 - 2030 (USD Million)

             12.1.4 North America Market, by Disease manifestation, 2021 - 2030 (USD Million)

                    Table 18: North America Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 52: North America Market, by Disease manifestation, 2021 - 2030 (USD Million)

              12.1.5 U.S.

                          12.1.5.1 U.S. Market, by Type, 2021 - 2030 (USD Million)

              Figure 53: U.S. Market, by Type, 2021 - 2030 (USD Million)

                           12.1.5.2 U.S. Market, by End-User, 2021 - 2030 (USD Million)

              Figure 54: U.S. Market, by End-User, 2021 - 2030 (USD Million)

                           12.1.5.3 U.S. Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 55: U.S. Market, by Disease manifestation, 2021 - 2030 (USD Million)

              12.1.6 Canada

                           12.1.6.1 Canada Market, by Type, 2021 - 2030 (USD Million)

               Figure 56: Canada Market, by Type, 2021 - 2030 (USD Million)

                           12.1.6.2 Canada Market, by End-User, 2021 - 2030 (USD Million)

               Figure 57: Canada Market, by End-User, 2021 - 2030 (USD Million)

                           12.1.6.3 Canada Market, by Disease manifestation, 2021 - 2030 (USD Million)

               Figure 58: Canada Market, by End-User, 2021 - 2030 (USD Million)

                           12.1.6.4 Canada Market, by Disease manifestation, 2021 - 2030 (USD Million)

               Figure 59: Canada Market, by End-User, 2021 - 2030 (USD Million)

     12.2 Europe

              Figure 60: Europe Market, By Revenue Forecast (2021-2030)

              12.2.1 Europe Market, by country, 2021 - 2030 (USD Million)

                             Table 19: Europe Market, by country, 2021 - 2030 (USD Million)

              Figure 61: Europe Market, by country, 2021 - 2030 (USD Million)

              12.2.2 Europe Market, by Type, 2021 - 2030 (USD Million)

                             Table 20: Europe Market, by Type, 2021 - 2030 (USD Million)

              Figure 62: Europe Market, by Type, 2021 - 2030 (USD Million)

             12.2.3 Europe Market, by End-User, 2021 - 2030 (USD Million)

                             Table 21: Europe Market, by End-User, 2021 - 2030 (USD Million)

              Figure 63: Europe Market, by End-User, 2021 - 2030 (USD Million)

              12.2.4 Europe Market, by Disease manifestation, 2021 - 2030 (USD Million)

                             Table 22: Europe Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 64: Europe Market, by Disease manifestation, 2021 - 2030 (USD Million)

              12.2.5 U.K.

                          12.2.5.1 U.K. Market, by Type, 2021 - 2030 (USD Million)

              Figure 65: U.K. Market, by Type, 2021 - 2030 (USD Million)

                          12.2.5.2 U.K. Market, by End-User, 2021 - 2030 (USD Million)

              Figure 66: U.K. Market, by End-User, 2021 - 2030 (USD Million)

                          12.2.5.3 U.K. Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 67: U.K. Market, by Disease manifestation, 2021 - 2030 (USD Million)

              12.2.6 Germany

                          12.2.6.1 Germany Market, by Type, 2021 - 2030 (USD Million)

              Figure 68: Germany Market, by Type, 2021 - 2030 (USD Million)

                          12.2.6.2 Germany Market, by End-User, 2021 - 2030 (USD Million)

              Figure 69: Germany Market, by End-User, 2021 - 2030 (USD Million)

                          12.2.6.3 Germany Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 70: Germany Market, by Disease manifestation, 2021 - 2030 (USD Million)

              12.2.7 France

                          12.2.7.1 France Market, by Type, 2021 - 2030 (USD Million)

              Figure 71: France Market, by Type, 2021 - 2030 (USD Million)

                          12.2.7.2 France Market, by End-User, 2021 - 2030 (USD Million)

              Figure 72: France Market, by End-User, 2021 - 2030 (USD Million)

                          12.2.7.3 France Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 73: France Market, by Disease manifestation, 2021 - 2030 (USD Million)

              12.2.8 Rest of Europe

                          12.2.8.1 Rest of Europe Market, by Type, 2021 - 2030 (USD Million)

              Figure 74: Rest of Europe Market, by Type, 2021 - 2030 (USD Million)

                          12.2.8.2 Rest of Europe Market, by End-User, 2021 - 2030 (USD Million)

              Figure 75: Rest of Europe Market, by End-User, 2021 - 2030 (USD Million)

                          12.2.8.3 Rest of Europe Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 76: Rest of Europe Market, by Disease manifestation, 2021 - 2030 (USD Million)

     12.3 Asia Pacific

              Figure 77: Asia Pacific Market, By Revenue Forecast (2021-2030)

              12.3.1 Asia Pacific Market, by country, 2021 - 2030 (USD Million)

                          Table 23: Asia Pacific Market, by country, 2021 - 2030 (USD Million)

              Figure 78: Asia Pacific Market, by country, 2021 - 2030 (USD Million)

              12.3.2 Asia Pacific Market, by Type, 2021 - 2030 (USD Million)

                          Table 24: Asia Pacific Market, by Type, 2021 - 2030 (USD Million)

              Figure 79: Asia Pacific Market, by Type, 2021 - 2030 (USD Million)

             12.3.3 Asia Pacific Market, by End-User, 2021 - 2030 (USD Million)

                         Table 25: Asia Pacific Market, by End-User, 2021 - 2030 (USD Million)

             Figure 80: Asia Pacific Market, by End-User, 2021 - 2030 (USD Million)

             12.3.4 Asia Pacific Market, by Disease manifestation, 2021 - 2030 (USD Million)

                         Table 26: Asia Pacific Market, by Disease manifestation, 2021 - 2030 (USD Million)

             Figure 81: Asia Pacific Market, by Disease manifestation, 2021 - 2030 (USD Million)

             12.3.5 China

                         12.3.5.1 China Market, by Type, 2021 - 2030 (USD Million)

             Figure 82: China Market, by Type, 2021 - 2030 (USD Million)

                         12.3.5.2 China Market, by End-User, 2021 - 2030 (USD Million)

             Figure 83: China Market, by End-User, 2021 - 2030 (USD Million)

                         12.3.5.3 China Market, by Disease manifestation, 2021 - 2030 (USD Million)

             Figure 84: China Market, by Disease manifestation, 2021 - 2030 (USD Million)

             12.3.6 India

                         12.3.6.1 India Market, by Type, 2021 - 2030 (USD Million)

              Figure 85: India Market, by Type, 2021 - 2030 (USD Million)

                          12.3.6.2 India Market, by End-User, 2021 - 2030 (USD Million)

              Figure 86: India Market, by End-User, 2021 - 2030 (USD Million)

                          12.3.6.3 India Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 87: India Market, by Disease manifestation, 2021 - 2030 (USD Million)

              12.3.7 Japan

                         12.3.7.1 Japan Market, by Type, 2021 - 2030 (USD Million)

              Figure 88: Japan Market, by Type, 2021 - 2030 (USD Million)

                               12.3.7.2 Japan Market, by End-User, 2021 - 2030 (USD Million)

              Figure 89: Japan Market, by End-User, 2021 - 2030 (USD Million)

                                12.3.7.3 Japan Market, by Disease manifestation, 2021 - 2030 (USD Million)

               Figure 90: Japan Market, by Disease manifestation, 2021 - 2030 (USD Million)

               12.3.8 South Korea

                           12.3.8.1 South Korea Market, by Type, 2021 - 2030 (USD Million)

               Figure 91: South Korea Market, by Type, 2021 - 2030 (USD Million)

                           12.3.8.2 South Korea Market, by End-User, 2021 - 2030 (USD Million)

               Figure 92: South Korea Market, by End-User, 2021 - 2030 (USD Million)

                           12.3.8.3 South Korea Market, by Disease manifestation, 2021 - 2030 (USD Million)

               Figure 93: South Korea Market, by Disease manifestation, 2021 - 2030 (USD Million)

             12.3.9 Rest of APAC

                         12.3.9.1 Rest of APAC Market, by Type, 2021 - 2030 (USD Million)

              Figure 94: Rest of APAC Market, by Type, 2021 - 2030 (USD Million)

                         12.3.9.2 Rest of APAC Market, by End-User, 2021 - 2030 (USD Million)

              Figure 95: Rest of APAC Market, by End-User, 2021 - 2030 (USD Million)

                               12.3.9.3 Rest of APAC Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 96: Rest of APAC Market, by Disease manifestation, 2021 - 2030 (USD Million)

     12.4 Latin America

              Figure 97: Latin America Market, By Revenue Forecast (2021-2030)

             12.4.1 Latin America Market, by country, 2021 - 2030 (USD Million)

                         Table 27: Latin America Market, by country, 2021 - 2030 (USD Million)

             Figure 98: Latin America Market, by country, 2021 - 2030 (USD Million)

             12.4.2 Latin America Market, by Type, 2021 - 2030 (USD Million)

                         Table 28: Latin America Market, by Type, 2021 - 2030 (USD Million)

             Figure 99: Latin America Market, by Type, 2021 - 2030 (USD Million)

             12.4.3 Latin America Market, by End-User, 2021 - 2030 (USD Million)

                         Table 29: Latin America Market, by End-User, 2021 - 2030 (USD Million)

             Figure 100: Latin America Market, by End-User, 2021 - 2030 (USD Million)

             12.4.4 Latin America Market, by Disease manifestation, 2021 - 2030 (USD Million)

                         Table 30: Latin America Market, by Disease manifestation, 2021 - 2030 (USD Million)

             Figure 101: Latin America Market, by Disease manifestation, 2021 - 2030 (USD Million)

            12.4.5 Brazil

                       12.4.5.1 Brazil Market, by Type, 2021 - 2030 (USD Million)

            Figure 102: Brazil Market, by Type, 2021 - 2030 (USD Million)

                       12.4.5.2 Brazil Market, by End-User, 2021 - 2030 (USD Million)

            Figure 103: Brazil Market, by End-User, 2021 - 2030 (USD Million)

                       12.4.5.3 Brazil Market, by Disease manifestation, 2021 - 2030 (USD Million)

            Figure 104: Brazil Market, by Disease manifestation, 2021 - 2030 (USD Million)

            12.4.6 Mexico

                        12.4.6.1 Mexico Market, by Type, 2021 - 2030 (USD Million)

            Figure 105: Mexico Market, by Type, 2021 - 2030 (USD Million)

                         12.4.6 2 Mexico Market, by End-User, 2021 - 2030 (USD Million)

            Figure 106: Mexico Market, by End-User, 2021 - 2030 (USD Million)

                         12.4.6.3 Mexico Market, by Disease manifestation, 2021 - 2030 (USD Million)

             Figure 107: Mexico Market, by Disease manifestation, 2021 - 2030 (USD Million)

      12.4.7 Rest of the Latin America

                        12.4.7.1 Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million)

             Figure 108: Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million)

                         12.4.7.2 Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million)

              Figure 109: Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million)

                         12.4.7.3 Rest of the Latin America Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 110: Rest of the Latin America Market, by Disease manifestation, 2021 - 2030 (USD Million)

     12.5 MEA

              Figure 111: MEA Market, By Revenue Forecast (2021-2030)

              12.5.1 MEA Market, by Type, 2021 - 2030 (USD Million)

              Figure 112: MEA Market, by Type, 2021 - 2030 (USD Million)

              12.5.2 MEA Market, by End-User, 2021 - 2030 (USD Million)

              Figure 113: MEA Market, by End-User, 2021 - 2030 (USD Million)

              12.5.3 MEA Market, by Disease manifestation, 2021 - 2030 (USD Million)

              Figure 114: MEA Market, by Disease manifestation, 2021 - 2030 (USD Million)

Chapter 13. Competitive Landscape

     13.1 CorneaGen.

             13.1.1 Company overview

             13.1.2 Financial performance

             13.1.3 Product Portfolio Analysis

             13.1.4 Business Strategy & Recent Development

     13.2 AJL Ophthalmic.

             13.2 .1 Company overview

             13.2 .2 Financial performance

             13.2 .3 Product Portfolio Analysis

             13.2 .4 Business Strategy & Recent Development

     13.3 LinkoCare Life Sciences AB.

             13.3.1 Company overview

             13.3.2 Financial performance

             13.3.3 Product Portfolio Analysis

             13.3.4 Business Strategy & Recent Development

     13.4 Addition Technology.

             13.4.1 Company overview

             13.4.2 Financial performance

             13.4.3 Product Portfolio Analysis

             13.4.4 Business Strategy & Recent Development

     13.5 Mediphacos.

             13.5.1 Company overview

             13.5.2 Financial performance

             13.5.3 Product Portfolio Analysis

             13.5.4 Business Strategy & Recent Development

     13.6 Florida Lions Eye Bank.

             13.6.1 Company overview

             13.6.2 Financial performance

             13.6.3 Product Portfolio Analysis

             13.6.4 Business Strategy & Recent Development

     13.7 Presbia plc.

             13.7.1 Company overview

             13.7.2 Financial performance

             13.7.3 Product Portfolio Analysis

             13.7.4 Business Strategy & Recent Development

     13.8 Aurolab.

             13.8.1 Company overview

             13.8.2 Financial performance

             13.8.3 Product Portfolio Analysis

             13.8.4 Business Strategy & Recent Development

     13.9 EyeYon Medical.

             13.9.1 Company overview

             13.9.2 Financial performance

             13.9.3 Product Portfolio Analysis

             13.9.4 Business Strategy & Recent Development

     13.10 Advancing Sight Network.

             13.10.1 Company overview

             13.10.2 Financial performance

             13.10.3 Product Portfolio Analysis

             13.10.4 Business Strategy & Recent Development

     13.11 Massachusetts Eye and Ear.

             13.11.1 Company overview

             13.11.2 Financial performance

             13.11.3 Product Portfolio Analysis

             13.11.4 Business Strategy & Recent Development

     13.12 DIOPTEX GmbH.

             13.12.1 Company overview

             13.12.2 Financial performance

             13.12.3 Product Portfolio Analysis

             13.12.4 Business Strategy & Recent Development

     13.13 San Diego Eye Bank.

             13.13.1 Company overview

             13.13.2 Financial performance

             13.13.3 Product Portfolio Analysis

             13.13.4 Business Strategy & Recent Development

     13.14 SightLife.

             13.14.1 Company overview

             13.14.2 Financial performance

             13.14.3 Product Portfolio Analysis

             13.14.4 Business Strategy & Recent Development

     13.15 Cornea Biosciences.

             13.15.1 Company overview

             13.15.2 Financial performance

             13.15.3 Product Portfolio Analysis

             13.15.4 Business Strategy & Recent Development

Choose License Type


$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization
Related Reports
Buy Now
Request Sample

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: +1-315-636-4233
  • UK: +44-162-237-0614
  • IN: +91-826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.